Precision Business Insights
Portfolio

 

Cell Therapy Market

: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2019 and Forecast 2020-2026

Global Cell Therapy Market: By Type (Allogeneic and Autologous), By Technology (Cell Immortalization Technology, Cell Plasticity Technology, Genome Editing Technology, Somatic Cell Technology, Three-Dimensional Technology and Viral Vector Technology), By Cell Source (Stem Cell and Non-stem Cell), By Application (Cardiovascular, Dermatology, Gastrointestinal, Induced Pluripotent Stem Cells (iPSCs), Musculoskeletal, Neural Stem Cell, Neurological, Ocular, Oncology, Umbilical Cord Blood-Derived Cells, Wounds & Injuries and Others), By End User (Hospitals & Clinics, Regenerative Medicine Centers, Diagnostic & Research Centers and Others) and Geography

 

Global Cell Therapy Market Report Description:

 

Global cell therapy market report gives comprehensive outlook on cell therapy across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global cell therapy market gives historical, current, and future market sizes (US$ Mn) on the basis of type, technology, cell source, application, end-user and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global cell therapy market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global cell therapy market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global cell therapy market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global cell therapy products.

 

Global Cell Therapy Market:

 

The global cell therapy market estimated to be valued US$ 8.22 Bn in 2019 and poised to grow at significant CAGR nearly 13.3 % over 2020-2026. Rising in the number of medical research facilities and number of clinical trials centers for development of effective and novel medical solutions for patients as early as possible to diagnosis and treatment of chronic disease such as cancer, cardiac abnormalities and others. Furthermore, new innovations, technological advancement in the medical sector, and rising government initiatives for enhancing the better advance medical facilities will propel the market growth. However, high cost of research and low success rate are some of the factors expected to hinder the market growth.

 

Increasing Prevalence of Chronic Disease are fueling the Growth of the Cell Therapy Market

 

Changing in the lifestyle and food habits rising in numerous of chronic diseases such as cancer, cardiovascular disease, neurodegenerative disorder and others thus increasing in the demand of  huge number of advanced medical facilities which provide highly advanced treatment. Scientists are continuously researching and developing high-performance novel drug solutions thus to provide conventional diagnosis and treatment to the patients. Increasing government emphasis on clinical trials and cell therapy doses to develop the healthcare infrastructure. Moreover, rising disposable income, technological advancement and rising popularity of cell therapy will fuel the market growth during the forecast period.

 

North America Accounts for Larger Market Revenue Share in Global Cell Therapy Market

 

North America accounted for larger revenue share in global cell therapy market with considerable CAGR. The growth in this region, especially in USA and Canada can be attributed to rising in the medical center and cost effective treatment. For instance, government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies permitting development in stem cell therapy. European market dominates by advanced healthcare facility systems. European region is expected to dominate the market growth due to economically developed countries such as Germany, UK and France. In Asia Pacific cell therapy market is largely driven by the developing healthcare infrastructure, and skilled professionals, increase in disposable incomes.

 

Competition Assessment

 

Key player’s profiles in the global cell therapy market include:

  • ReproCELL
  • Prima BioMed
  • Q Therapeutics
  • Tessa Therapeutics
  • Sangamo BioSciences
  • VistaGen Therapeutics
  • Shire Regenerative Medicine
  • Bellicum Pharmaceuticals
  • Antibe Therapeutics
  • BrainStorm Cell Therapeutics
  • Capricor Therapeutics
  • Fate Therapeutics
  • Cytori Therapeutics
  • Holostem Terapie Avanzate
  • Immunocellular Therapeutics

 

Global cell therapy market is surging owing to frequent acquisitions and launchings by the market players. In 2018, Thermo Fisher Scientific launched an advanced laboratory management system for data integrity and complete regulatory compliance.

 

Key Findings of the Report:

 

  • Global cell therapy market expanding at significant CAGR over 2020 to 2026 due to increasing prevalence of chronic diseases.
  • Based on by type, technology, cell source, application and end-user cell therapy segment accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global cell therapy market.

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

By Type

  • Allogeneic
  • Autologous

By Technology

  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Three-Dimensional Technology
  • Viral Vector Technology
  • In-Vivo Gene Modification
  • Ex-Vivo Gene Modification

By Cell Source

  • Stem Cell
  • Bone Marrow
  • Blood
  • Umbilical Cord-Derived
  • Adipose-Derived Stem Cell
  • Others
  • Non-stem Cell

By Application

  • Cardiovascular
  • Dermatology
  • Gastrointestinal
  • Induced Pluripotent Stem Cells (iPSCs)
  • Musculoskeletal
  • Neural Stem Cell
  • Neurological
  • Ocular
  • Oncology
  • Umbilical Cord Blood-Derived Cells
  • Wounds & Injuries
  • Others

End User

  • Hospitals & Clinics
  • Regenerative Medicine Centers
  • Research Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Table of Content

  1. Executive Summary
  2. Global Cell Therapy Market Introduction
    • Global Cell Therapy Market – Taxonomy
    • Global Cell Therapy Market –Definitions
      • By Type
      • By Technology
      • By Cell Source
      • By Application 
      • By End User           
  1. Global Cell Therapy Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cell Therapy Market Dynamic Factors – Impact Analysis
    • Global Cell Therapy Market – Competition Landscape
  2. Global Cell Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Cell Therapy Market, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Allogeneic
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Autologous
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cell Therapy Market, By Technology, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Cell Immortalization Technology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cell Plasticity Technology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Genome Editing Technology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Somatic Cell Technology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Three-Dimensional Technology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Viral Vector Technology
      • In-Vivo Gene Modification
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Ex-Vivo Gene Modification
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Cell Therapy Market, By Cell Source, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Stem Cell 
      • Bone Marrow 
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Blood
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Umbilical Cord-Derived 
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Adipose-Derived Stem Cell
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others 
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Non-stem Cell
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Cell Therapy Market, By Application, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Cardiovascular
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dermatology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gastrointestinal
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Induced Pluripotent Stem Cells (iPSCs)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Musculoskeletal
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Neural Stem Cell
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Neurological
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ocular
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Oncology
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Umbilical Cord Blood-Derived Cells
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Wounds & Injuries
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cell Therapy Market, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospitals & Clinics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Regenerative Medicine Centers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Research Centers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cell Therapy Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cell Therapy Market – Opportunity Analysis Index, By Type, By Technology, By Cell Source, Application, End User, and Region, 2020 – 2026
  2. North America Cell Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • By Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • By Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cell Immortalization Technology
      • Cell Plasticity Technology
      • Genome Editing Technology
      • Somatic Cell Technology
      • Three-Dimensional Technology
      • Viral Vector Technology
        • In-Vivo Gene Modification
        • Ex-Vivo Gene Modification
      • By Cell Source Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Stem Cell 
          • Bone Marrow 
          • Blood
          • Umbilical Cord-Derived 
          • Adipose-Derived Stem Cell
          • Others 
        • Non-stem Cell
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Cardiovascular
        • Dermatology
        • Gastrointestinal
        • Induced Pluripotent Stem Cells (iPSCs)
        • Musculoskeletal
        • Neural Stem Cell
        • Neurological
        • Ocular
        • Oncology
        • Umbilical Cord Blood-Derived Cells
        • Wounds & Injuries
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Regenerative Medicine Centers
        • Research Centers
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • USA
        • Canada
      • North America Cell Therapy Market – Opportunity Analysis Index, By Type, By Technology, By Cell Source, Application, End User, 2020 – 2026
      • North America Cell Therapy Market Dynamics – Trends
  1. Europe Cell Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • By Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • By Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cell Immortalization Technology
      • Cell Plasticity Technology
      • Genome Editing Technology
      • Somatic Cell Technology
      • Three-Dimensional Technology
      • Viral Vector Technology
        • In-Vivo Gene Modification
        • Ex-Vivo Gene Modification
      • By Cell Source Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Stem Cell 
          • Bone Marrow 
          • Blood
          • Umbilical Cord-Derived 
          • Adipose-Derived Stem Cell
          • Others 
        • Non-stem Cell
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Cardiovascular
        • Dermatology
        • Gastrointestinal
        • Induced Pluripotent Stem Cells (iPSCs)
        • Musculoskeletal
        • Neural Stem Cell
        • Neurological
        • Ocular
        • Oncology
        • Umbilical Cord Blood-Derived Cells
        • Wounds & Injuries
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Regenerative Medicine Centers
        • Research Centers
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Cell Therapy Market – Opportunity Analysis Index, By Type, By Technology, By Cell Source, Application, End User, and Country, 2020 – 2026
      • Europe Cell Therapy Market Dynamics – Trends
  1. Asia-Pacific Cell Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • By Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • By Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cell Immortalization Technology
      • Cell Plasticity Technology
      • Genome Editing Technology
      • Somatic Cell Technology
      • Three-Dimensional Technology
      • Viral Vector Technology
        • In-Vivo Gene Modification
        • Ex-Vivo Gene Modification
      • By Cell Source Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Stem Cell 
          • Bone Marrow 
          • Blood
          • Umbilical Cord-Derived 
          • Adipose-Derived Stem Cell
          • Others 
        • Non-stem Cell
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Cardiovascular
        • Dermatology
        • Gastrointestinal
        • Induced Pluripotent Stem Cells (iPSCs)
        • Musculoskeletal
        • Neural Stem Cell
        • Neurological
        • Ocular
        • Oncology
        • Umbilical Cord Blood-Derived Cells
        • Wounds & Injuries
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Regenerative Medicine Centers
        • Research Centers
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Cell Therapy Market – Opportunity Analysis Index, By Type, By Technology, By Cell Source, Application, End User, and Country, 2020 – 2026
      • Asia-Pacific Cell Therapy Market Dynamics – Trends
  1. Latin America Cell Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • By Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • By Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cell Immortalization Technology
      • Cell Plasticity Technology
      • Genome Editing Technology
      • Somatic Cell Technology
      • Three-Dimensional Technology
      • Viral Vector Technology
        • In-Vivo Gene Modification
        • Ex-Vivo Gene Modification
      • By Cell Source Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Stem Cell 
          • Bone Marrow 
          • Blood
          • Umbilical Cord-Derived 
          • Adipose-Derived Stem Cell
          • Others 
        • Non-stem Cell
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Cardiovascular
        • Dermatology
        • Gastrointestinal
        • Induced Pluripotent Stem Cells (iPSCs)
        • Musculoskeletal
        • Neural Stem Cell
        • Neurological
        • Ocular
        • Oncology
        • Umbilical Cord Blood-Derived Cells
        • Wounds & Injuries
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Regenerative Medicine Centers
        • Research Centers
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Cell Therapy Market – Opportunity Analysis Index, By Type, By Technology, By Cell Source, Application, End User, and Country, 2020 – 2026
      • Latin America Cell Therapy Market Dynamics – Trends
  1. Middle East and Africa Cell Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • By Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • By Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cell Immortalization Technology
      • Cell Plasticity Technology
      • Genome Editing Technology
      • Somatic Cell Technology
      • Three-Dimensional Technology
      • Viral Vector Technology
        • In-Vivo Gene Modification
        • Ex-Vivo Gene Modification
      • By Cell Source Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Stem Cell 
          • Bone Marrow 
          • Blood
          • Umbilical Cord-Derived 
          • Adipose-Derived Stem Cell
          • Others 
        • Non-stem Cell
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Cardiovascular
        • Dermatology
        • Gastrointestinal
        • Induced Pluripotent Stem Cells (iPSCs)
        • Musculoskeletal
        • Neural Stem Cell
        • Neurological
        • Ocular
        • Oncology
        • Umbilical Cord Blood-Derived Cells
        • Wounds & Injuries
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Regenerative Medicine Centers
        • Research Centers
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Cell Therapy Market – Opportunity Analysis Index, By Type, By Technology, By Cell Source, Application, End User, and Country, 2020 – 2026
      • MEA Cell Therapy Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • ReproCELL
      • Prima BioMed
      • Q Therapeutics
      • Tessa Therapeutics
      • Sangamo BioSciences
      • VistaGen Therapeutics
      • Shire Regenerative Medicine
      • Bellicum Pharmaceuticals
      • Antibe Therapeutics
      • BrainStorm Cell Therapeutics
      • Capricor Therapeutics
      • Fate Therapeutics
      • Cytori Therapeutics
      • Holostem Terapie Avanzate
      • Immunocellular Therapeutics
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.